Is It Prime Time for Perioperative Therapy in Patients With Resectable Non-Small-Cell Lung Cancer?

JCO Oncol Pract. 2023 Sep;19(9):685-687. doi: 10.1200/OP.23.00266. Epub 2023 Aug 4.

Authors

Badi El Osta^{1

2

3}, Obada Ababneh⁴

Affiliations

¹ Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
² Atlanta VA Medical Center, Atlanta, GA.
³ Winship Cancer Institute of Emory University, Atlanta, GA.
⁴ Faculty of Medicine, Jordan University of Science and Technology; Irbid, Jordan.

PMID: 37540820
DOI: 10.1200/OP.23.00266

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Lung Neoplasms* / therapy